{"transactions":[{"id":2738419,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-04-27T20:02:21.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":4,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Arrangement Agreement, dated as of February 6, 2021 (as amended, the \"Arrangement Agreement\"), by and among CRH Medical Corporation (\"CRH\"), WELL Health Technologies Corp. (\"WELL\"), WELL Health Acquisition Corp., a wholly owned subsidiary of WELL, and 1286392 B.C. Ltd, a wholly owned subsidiary of WELL, at 4:30 p.m. Eastern Time (the \"Effective Time\") on April 22, 2021 each common share of CRH (each, a \"CRH share\") issued and outstanding immediately before the Effective Time was transferred to a subsidiary of WELL, and the holders thereof became entitled to receive US$4.00 in cash, without interest and less any applicable withholding taxes (the \"Share Consideration\"), for each CRH share then held."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each CRH RSU represented a contingent right to receive one CRH share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All options to acquire CRH shares (\"CRH options\") and share units with respect to CRH shares (\"CRH RSUs\") outstanding immediately prior to the Effective Time were exchanged for either a cash payment equal to Share Consideration (less the applicable exercise price in respect of CRH options) or replacement options or restricted stock units with respect to WELL common shares, in accordance with the terms of the Arrangement Agreement and the plan of arrangement subject to the same vesting schedule as applied to the CRH RSUs."}],"balance_after":0,"derivative":{"expiration_date":"2021-06-11","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-028730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919121028730/doc4.xml","form_type":"4"}},{"id":2738418,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-04-27T20:02:21.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":4,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Arrangement Agreement, dated as of February 6, 2021 (as amended, the \"Arrangement Agreement\"), by and among CRH Medical Corporation (\"CRH\"), WELL Health Technologies Corp. (\"WELL\"), WELL Health Acquisition Corp., a wholly owned subsidiary of WELL, and 1286392 B.C. Ltd, a wholly owned subsidiary of WELL, at 4:30 p.m. Eastern Time (the \"Effective Time\") on April 22, 2021 each common share of CRH (each, a \"CRH share\") issued and outstanding immediately before the Effective Time was transferred to a subsidiary of WELL, and the holders thereof became entitled to receive US$4.00 in cash, without interest and less any applicable withholding taxes (the \"Share Consideration\"), for each CRH share then held."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each CRH RSU represented a contingent right to receive one CRH share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All options to acquire CRH shares (\"CRH options\") and share units with respect to CRH shares (\"CRH RSUs\") outstanding immediately prior to the Effective Time were exchanged for either a cash payment equal to Share Consideration (less the applicable exercise price in respect of CRH options) or replacement options or restricted stock units with respect to WELL common shares, in accordance with the terms of the Arrangement Agreement and the plan of arrangement subject to the same vesting schedule as applied to the CRH RSUs."}],"balance_after":0,"derivative":{"expiration_date":"2024-05-26","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-028730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919121028730/doc4.xml","form_type":"4"}},{"id":3110484,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit","published_at":"2020-06-15T20:09:17.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Share Units vest on or before expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Share Units will expire on the earlier of June 30, 2021 or one day prior to the next Annual General Meeting of the Issuer."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919120036820/doc4.xml","form_type":"4"}},{"id":3132084,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit","published_at":"2020-05-28T16:15:00.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Share Units vest 25% on the first year anniversary, 25% on the second year anniversary, 25% on the third year anniversary and the final 25% on the expiration date."}],"balance_after":50000,"derivative":{"expiration_date":"2024-05-26","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-032582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919120032582/doc4.xml","form_type":"4"}},{"id":3281860,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":290198,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third of the options vest on each of the first, second and third anniversary of the grant date (June 4, 2019)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":0,"derivative":{"exercise_price":337.78,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":290198},"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281859,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":81351,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the options vest on each of the first, second and third anniversary of the grant date (June 4, 2018)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":0,"derivative":{"exercise_price":1705.75,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":81351},"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281858,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":204457,"price":4,"value":817828.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, certain vested restricted stock unit awards held by reporting person were disposed of pursuant to the closing on February 10, 2020 of the Tender Offer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281857,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":583580,"price":4,"value":2334320.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, certain vested restricted stock unit awards held by reporting person were disposed of pursuant to the closing on February 10, 2020 of the Tender Offer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":204457,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281856,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":408915,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":788037,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281855,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":84375,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":1196952,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281854,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":22478,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the \"Merger Agreement\"), by and among UnitedHealth Group Incorporated, a Delaware corporation (\"Parent\"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the \"Issuer\"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":1281327,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281853,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"other","acquired":false,"shares":124875,"price":4,"value":499500.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares tendered to the Denali Merger Sub, Inc. (\"Purchaser\") in connection with the closing on February 10, 2020 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $4.00 per share in cash, subject to any required withholding of taxes, without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":1303805,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3281852,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-10T16:16:04.000Z","date":"2020-02-10","kind":"other","acquired":false,"shares":11238,"price":4,"value":44952.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares tendered to the Denali Merger Sub, Inc. (\"Purchaser\") in connection with the closing on February 10, 2020 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $4.00 per share in cash, subject to any required withholding of taxes, without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-013506","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000110465920013506/a4.xml","form_type":"4"}},{"id":3286346,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-06T19:05:46.000Z","date":"2020-02-04","kind":"grant","acquired":true,"shares":613372,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On June 4, 2019, reporting person was granted restricted stock units that were subject to the Issuer's satisfaction of certain financial performance criteria.  On February 4, 2020 (the \"determination date\"), the performance criteria was met with respect to 613,372 restricted stock units.  One-third of the restricted stock units vested upon the determination date, and the remaining two-thirds will vest in two equal installments on each anniversary of the determination date, subject to continued employment."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":1428680,"source":{"system":"sec-edgar","filing":"0001596771-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677120000001/primary_doc.xml","form_type":"4"}},{"id":3286345,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2020-02-06T19:05:46.000Z","date":"2020-02-04","kind":"grant","acquired":true,"shares":583580,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY grantor retained annuity trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 4, 2018, reporting person was granted restricted stock units that were subject to the Issuer's satisfaction of certain financial performance criteria. On February 4, 2020 (the \"determination date\"), the performance criteria was met with respect to 583,580 restricted stock units all of which vested upon the determination date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II."}],"balance_after":815308,"source":{"system":"sec-edgar","filing":"0001596771-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677120000001/primary_doc.xml","form_type":"4"}},{"id":3498652,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2019-06-06T16:03:45.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":290198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted in connection with the Issuer's equity incentive plan. One-third of the options will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":290198,"derivative":{"exercise_price":4.81,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":290198},"source":{"system":"sec-edgar","filing":"0001596771-19-000059","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677119000059/primary_doc.xml","form_type":"4"}},{"id":3498651,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2019-06-06T16:03:45.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":84375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":242966,"source":{"system":"sec-edgar","filing":"0001596771-19-000059","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677119000059/primary_doc.xml","form_type":"4"}},{"id":3903161,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2018-06-06T16:38:31.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":81351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents an inducement award of stock options to the reporting person in connection with his appointment as CEO and Chairman. One-third of the options will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":81351,"derivative":{"exercise_price":24.29,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":81351},"source":{"system":"sec-edgar","filing":"0001596771-18-000076","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677118000076/primary_doc.xml","form_type":"4"}},{"id":3903160,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2018-06-06T16:38:31.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":124875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (\"RSUs\") represent an inducement award of stock to the reporting person in connection with his appointment as CEO and Chairman."},{"field":"shares","element":"transactionShares","label":"F3","text":"The RSUs will vest on the first anniversary of the grant date, provided the vesting of these RSUs may be accelerated based on the achievement of a specified stock price performance goal."}],"balance_after":158591,"source":{"system":"sec-edgar","filing":"0001596771-18-000076","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677118000076/primary_doc.xml","form_type":"4"}},{"id":3903159,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2018-06-06T16:38:31.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":33716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (\"RSUs\") represent an inducement award of stock to the reporting person in connection with his appointment as CEO and Chairman."},{"field":"shares","element":"transactionShares","label":"F2","text":"One-third of the RSUs will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":33716,"source":{"system":"sec-edgar","filing":"0001596771-18-000076","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1252006/000159677118000076/primary_doc.xml","form_type":"4"}},{"id":3944428,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":6636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date."}],"balance_after":13272,"derivative":{"exercise_price":166.97,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":6636},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944427,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":16232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date."}],"balance_after":8116,"derivative":{"exercise_price":131.8,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":16232},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944426,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":4478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option represents a right to purchase a total of 5,374 shares, and is exercisable in six semi-annual installments, with two installments of 895 shares each and four installments of 896 shares each, beginning on February 3, 2016, which is the six-month anniversary of the option grant date."}],"balance_after":896,"derivative":{"exercise_price":152.78,"expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":4478},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944425,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":14830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 14,830 shares, and is exercisable in six semi-annual installments, with two installments of 2,471 shares each and four installments of 2,472 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date."}],"balance_after":0,"derivative":{"exercise_price":89.44,"expiration_date":"2021-03-03","underlying":"Common Stock","underlying_shares":14830},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944424,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":7489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 7,489 shares, and is exercisable in five semi-annual installments of 1,248 shares each and one  installment of 1,249 shares, beginning on September 2, 2015, which is the six-month anniversary of the option grant date."}],"balance_after":0,"derivative":{"exercise_price":146.93,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":7489},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944423,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":9756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 9,756 shares, and is exercisable in six  semi-annual installments of 1,626 shares each, beginning on September 1, 2013, which is the six-month anniversary of the  option grant date."}],"balance_after":0,"derivative":{"exercise_price":61.88,"expiration_date":"2020-03-01","underlying":"Common Stock","underlying_shares":9756},"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944422,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"sale","acquired":false,"shares":4924,"price":225.35,"value":1109623.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $225.15 to $225.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff,\nthe issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15863,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944421,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"sale","acquired":false,"shares":54497,"price":224.32,"value":12224767.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $224.13 to $225.10. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff,\nthe issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20787,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944420,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":6636,"price":166.97,"value":1108012.92,"ownership":{"direct":true},"balance_after":75284,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944419,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":16232,"price":131.8,"value":2139377.6,"ownership":{"direct":true},"balance_after":68648,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944418,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":4478,"price":152.78,"value":684148.84,"ownership":{"direct":true},"balance_after":52416,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944417,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":14830,"price":89.44,"value":1326395.2,"ownership":{"direct":true},"balance_after":47938,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944416,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":7489,"price":146.93,"value":1100358.77,"ownership":{"direct":true},"balance_after":33108,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":3944415,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & CEO, IngenioRx"}}],"security":"Common Stock","published_at":"2018-05-07T20:19:42.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":9756,"price":61.88,"value":603701.28,"ownership":{"direct":true},"balance_after":25619,"source":{"system":"sec-edgar","filing":"0001127602-18-016509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218016509/form4.xml","form_type":"4"}},{"id":4016027,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-05T21:44:33.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":14761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date."}],"balance_after":14761,"derivative":{"exercise_price":232.04,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":14761},"source":{"system":"sec-edgar","filing":"0001127602-18-010098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010098/form4.xml","form_type":"4"}},{"id":4016026,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2018-03-05T21:44:33.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":5462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/18."}],"balance_after":15863,"source":{"system":"sec-edgar","filing":"0001127602-18-010098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010098/form4.xml","form_type":"4"}},{"id":4016025,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2018-03-05T21:44:33.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":2259,"price":233.08,"value":526527.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":10401,"source":{"system":"sec-edgar","filing":"0001127602-18-010098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010098/form4.xml","form_type":"4"}},{"id":4016024,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2018-03-05T21:44:33.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":3502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021."}],"balance_after":12660,"source":{"system":"sec-edgar","filing":"0001127602-18-010098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010098/form4.xml","form_type":"4"}},{"id":4016023,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2018-03-05T21:44:33.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":856,"price":232.04,"value":198626.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":9158,"source":{"system":"sec-edgar","filing":"0001127602-18-010098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010098/form4.xml","form_type":"4"}},{"id":4241441,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-08-07T20:34:02.000Z","date":"2017-08-03","kind":"tax_withholding","acquired":false,"shares":213,"price":191.44,"value":40776.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":20078,"source":{"system":"sec-edgar","filing":"0001127602-17-025138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217025138/form4.xml","form_type":"4"}},{"id":4358574,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-04-05T20:02:11.000Z","date":"2017-04-03","kind":"tax_withholding","acquired":false,"shares":2356,"price":166.49,"value":392250.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":20291,"source":{"system":"sec-edgar","filing":"0001127602-17-014313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217014313/form4.xml","form_type":"4"}},{"id":4397764,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-03-07T21:19:01.000Z","date":"2017-03-03","kind":"tax_withholding","acquired":false,"shares":1963,"price":166,"value":325858.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":22647,"source":{"system":"sec-edgar","filing":"0001127602-17-010583","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010583/form4.xml","form_type":"4"}},{"id":4404881,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T21:41:00.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":19908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date."}],"balance_after":19908,"derivative":{"exercise_price":166.97,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":19908},"source":{"system":"sec-edgar","filing":"0001127602-17-010201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010201/form4.xml","form_type":"4"}},{"id":4404880,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-03-03T21:41:00.000Z","date":"2017-03-02","kind":"tax_withholding","acquired":false,"shares":213,"price":165.97,"value":35351.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":24610,"source":{"system":"sec-edgar","filing":"0001127602-17-010201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010201/form4.xml","form_type":"4"}},{"id":4404879,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-03-03T21:41:00.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":4867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020."}],"balance_after":24823,"source":{"system":"sec-edgar","filing":"0001127602-17-010201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010201/form4.xml","form_type":"4"}},{"id":4404878,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":140000,"kind":"person","name":"GRIFFIN BRIAN T","position":1,"cik":"0001252006","reported_name":"GRIFFIN BRIAN T","relationship":{"officer":true,"officer_title":"EVP & President, CSBD"}}],"security":"Common Stock","published_at":"2017-03-03T21:41:00.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":706,"price":166.97,"value":117880.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":19956,"source":{"system":"sec-edgar","filing":"0001127602-17-010201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010201/form4.xml","form_type":"4"}}]}